These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 26307001

  • 1. Inhibition of the alternative complement pathway by antisense oligonucleotides targeting complement factor B improves lupus nephritis in mice.
    Grossman TR, Hettrick LA, Johnson RB, Hung G, Peralta R, Watt A, Henry SP, Adamson P, Monia BP, McCaleb ML.
    Immunobiology; 2016 Jun; 221(6):701-8. PubMed ID: 26307001
    [Abstract] [Full Text] [Related]

  • 2. Modulation of renal disease in MRL/lpr mice genetically deficient in the alternative complement pathway factor B.
    Watanabe H, Garnier G, Circolo A, Wetsel RA, Ruiz P, Holers VM, Boackle SA, Colten HR, Gilkeson GS.
    J Immunol; 2000 Jan 15; 164(2):786-94. PubMed ID: 10623824
    [Abstract] [Full Text] [Related]

  • 3. BTK inhibition ameliorates kidney disease in spontaneous lupus nephritis.
    Chalmers SA, Glynn E, Garcia SJ, Panzenbeck M, Pelletier J, Dimock J, Seccareccia E, Bosanac T, Khalil S, Harcken C, Webb D, Nabozny G, Fine JS, Souza D, Klein E, Herlitz L, Ramanujam M, Putterman C.
    Clin Immunol; 2018 Dec 15; 197():205-218. PubMed ID: 30339790
    [Abstract] [Full Text] [Related]

  • 4. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
    Cash H, Relle M, Menke J, Brochhausen C, Jones SA, Topley N, Galle PR, Schwarting A.
    J Rheumatol; 2010 Jan 15; 37(1):60-70. PubMed ID: 19955044
    [Abstract] [Full Text] [Related]

  • 5. Effects of complement factor D deficiency on the renal disease of MRL/lpr mice.
    Elliott MK, Jarmi T, Ruiz P, Xu Y, Holers VM, Gilkeson GS.
    Kidney Int; 2004 Jan 15; 65(1):129-38. PubMed ID: 14675043
    [Abstract] [Full Text] [Related]

  • 6. Complement factor B inhibitor LNP023 improves lupus nephritis in MRL/lpr mice.
    Chen K, Deng Y, Shang S, Tang L, Li Q, Bai X, Chen X.
    Biomed Pharmacother; 2022 Sep 15; 153():113433. PubMed ID: 36076550
    [Abstract] [Full Text] [Related]

  • 7. Essential Roles for Mannose-Binding Lectin-Associated Serine Protease-1/3 in the Development of Lupus-Like Glomerulonephritis in MRL/lpr Mice.
    Machida T, Sakamoto N, Ishida Y, Takahashi M, Fujita T, Sekine H.
    Front Immunol; 2018 Sep 15; 9():1191. PubMed ID: 29892304
    [Abstract] [Full Text] [Related]

  • 8. Low-dose targeted complement inhibition protects against renal disease and other manifestations of autoimmune disease in MRL/lpr mice.
    Atkinson C, Qiao F, Song H, Gilkeson GS, Tomlinson S.
    J Immunol; 2008 Jan 15; 180(2):1231-8. PubMed ID: 18178863
    [Abstract] [Full Text] [Related]

  • 9. Absence of functional alternative complement pathway alleviates lupus cerebritis.
    Alexander JJ, Jacob A, Vezina P, Sekine H, Gilkeson GS, Quigg RJ.
    Eur J Immunol; 2007 Jun 15; 37(6):1691-701. PubMed ID: 17523212
    [Abstract] [Full Text] [Related]

  • 10. The benefit of targeted and selective inhibition of the alternative complement pathway for modulating autoimmunity and renal disease in MRL/lpr mice.
    Sekine H, Kinser TT, Qiao F, Martinez E, Paulling E, Ruiz P, Gilkeson GS, Tomlinson S.
    Arthritis Rheum; 2011 Apr 15; 63(4):1076-85. PubMed ID: 21452327
    [Abstract] [Full Text] [Related]

  • 11. Complement receptor of the immunoglobulin superfamily reduces murine lupus nephritis and cutaneous disease.
    Lieberman LA, Mizui M, Nalbandian A, Bossé R, Crispín JC, Tsokos GC.
    Clin Immunol; 2015 Oct 15; 160(2):286-91. PubMed ID: 25988858
    [Abstract] [Full Text] [Related]

  • 12. The dual role of complement in the progression of renal disease in NZB/W F(1) mice and alternative pathway inhibition.
    Sekine H, Ruiz P, Gilkeson GS, Tomlinson S.
    Mol Immunol; 2011 Oct 15; 49(1-2):317-23. PubMed ID: 22000720
    [Abstract] [Full Text] [Related]

  • 13. Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice.
    Lichtnekert J, Rupanagudi KV, Kulkarni OP, Darisipudi MN, Allam R, Anders HJ.
    J Immunol; 2011 Sep 15; 187(6):3413-21. PubMed ID: 21849682
    [Abstract] [Full Text] [Related]

  • 14. Local extrahepatic expression of complement genes C3, factor B, C2, and C4 is increased in murine lupus nephritis.
    Passwell J, Schreiner GF, Nonaka M, Beuscher HU, Colten HR.
    J Clin Invest; 1988 Nov 15; 82(5):1676-84. PubMed ID: 3183062
    [Abstract] [Full Text] [Related]

  • 15. Complement component C3 is not required for full expression of immune complex glomerulonephritis in MRL/lpr mice.
    Sekine H, Reilly CM, Molano ID, Garnier G, Circolo A, Ruiz P, Holers VM, Boackle SA, Gilkeson GS.
    J Immunol; 2001 May 15; 166(10):6444-51. PubMed ID: 11342671
    [Abstract] [Full Text] [Related]

  • 16. Function of the Th17/interleukin-17A immune response in murine lupus nephritis.
    Schmidt T, Paust HJ, Krebs CF, Turner JE, Kaffke A, Bennstein SB, Koyro T, Peters A, Velden J, Hünemörder S, Haag F, Steinmetz OM, Mittrücker HW, Stahl RA, Panzer U.
    Arthritis Rheumatol; 2015 Feb 15; 67(2):475-87. PubMed ID: 25385550
    [Abstract] [Full Text] [Related]

  • 17. Regulation of plasma complement C4 and factor b levels in murine systemic lupus erythematosus.
    Garlepp MJ, Hart DA, Fritzler MJ.
    J Clin Lab Immunol; 1989 Mar 15; 28(3):137-41. PubMed ID: 2738911
    [Abstract] [Full Text] [Related]

  • 18. Piperlongumine alleviates lupus nephritis in MRL-Fas(lpr) mice by regulating the frequency of Th17 and regulatory T cells.
    Yao L, Chen HP, Ma Q.
    Immunol Lett; 2014 Sep 15; 161(1):76-80. PubMed ID: 24837470
    [Abstract] [Full Text] [Related]

  • 19. Soluble receptor for advanced glycation end products alleviates nephritis in (NZB/NZW)F1 mice.
    Lee SW, Park KH, Park S, Kim JH, Hong SY, Lee SK, Choi D, Park YB.
    Arthritis Rheum; 2013 Jul 15; 65(7):1902-12. PubMed ID: 23553192
    [Abstract] [Full Text] [Related]

  • 20. CXCR3 promotes the production of IgG1 autoantibodies but is not essential for the development of lupus nephritis in NZB/NZW mice.
    Moser K, Kalies K, Szyska M, Humrich JY, Amann K, Manz RA.
    Arthritis Rheum; 2012 Apr 15; 64(4):1237-46. PubMed ID: 22006377
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.